阿兹海默症药物市场按药物类别、给药途径、分销管道和地区划分

2025 年全球阿兹海默症药物市场规模估计为 56.4 亿美元，预计到 2032 年将达到 113.4 亿美元，2025 年至 2032 年的复合年增长率为 10.5%。

数字。 2025 年阿兹海默症治疗市场占有率（按地区划分）

阿兹海默症是一种进行性的神经退化性疾病逐渐破坏记忆力和认知能力。它是老年人失智症最常见的原因。全球阿兹海默症药物市场的成长是由世界范围阿兹海默症患者病率的不断上升所推动的。根据世界卫生组织统计，全球约有5,000万人患有失智症，每年新增病例近1,000万人。在预测期内，针对阿兹海默症的潜在病理生理学的新型缓解疾病药物的核准和上市增加可能会推动市场成长。

市场动态

全球阿兹海默症药物市场的成长得益于老年人口的增加、阿兹海默症率的上升、新型缓解疾病药物的采用、医疗保健支出的增加以及对阿兹海默症认识的不断提高。然而，药物研发的高成本和后期临床试验的失败可能会阻碍市场的成长。老龄人口众多的开发中地区存在着巨大的成长机会。此外，早期诊断的技术进步和阐明疾病病理的进展也可能提供新的商业机会。

研究的主要特点

本报告对全球阿兹海默症药物市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。

它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。

全球阿兹海默症症药物市场的主要企业根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行分析。

研究涉及的主要企业包括 AbbVie, Inc.、Teva Pharmaceuticals Ltd.、Eisai Co., Ltd.、Janssen Pharmaceuticals, Inc. (Johnson & Johnson)、Novartis AG、Zydus Lifesciences Ltd (CADILA)、Sun Pharmaceutical .、Macleods Pharmaceuticals Ltd.、Viatris Inc.、Lupin Ltd.、Cipla Ltd.、Torrent Pharmaceuticals Ltd. 和 Unichem laboratories ltd.以及 Lannett Inc.

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球阿兹海默症治疗药物市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员可以透过全球阿兹海默症症药物市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球阿兹海默症药物市场-冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球阿兹海默症药物市场（按药物类别划分）（十亿美元）

• 介绍
• 胆碱酯酶抑制剂
• 多奈哌齐
• Rivastigmine
• Galantamine
• NMDA 受体拮抗剂
• Memantine
• 联合治疗
• 多奈哌齐Memantine
• 研发药物
• 阿杜卡努马
• 莱卡尼单抗
• 多纳尼单抗

6. 2020 年至 2032 年按给药途径分類的全球阿兹海默症药物市场（十亿美元）

• 介绍
• 口服
• 肠外
• 其他的

7. 2020-2032 年全球阿兹海默症药物市场按分销管道划分（十亿美元）

• 介绍
• 医院药房
• 零售药局
• 网路药局

8. 2020 年至 2032 年全球阿兹海默症药物市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第九章 竞争格局

• 公司简介
  • AbbVie, Inc.
  • Teva Pharmaceuticals Ltd.
  • Eisai Co., Ltd.
  • Janssen Pharmaceuticals, Inc.（Johnson & Johnson）
  • Novartis AG
  • Zydus Lifesciences Ltd（CADILA）
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Amneal Pharmaceuticals Inc.
  • Macleods Pharmaceuticals Ltd.
  • Viatris Inc.
  • Lupin Ltd
  • Cipla Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Unichem laboratories ltd
  • Lannett Inc.

第 10 章分析师建议

• 兴衰
• 一致的机会地图

第 11 章 参考文献与调查方法

• 参考
• 调查方法

Global Alzheimers Drugs Market is estimated to be valued at USD 5.64 Bn in 2025 and is expected to reach USD 11.34 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.

Figure. Alzheimers Drugs Market Share (%), By Region 2025

Alzheimer's disease is a progressive neurodegenerative disease that slowly destroys memory and cognitive skills. It is the most common cause of dementia among older people. Global Alzheimer's drugs market growth is driven by rising prevalence of Alzheimer's disease worldwide. According to WHO, around 50 million people globally have dementia with nearly 10 million new cases every year. Rising approval and launch of novel disease modifying drugs that target the underlying pathophysiology of Alzheimer's can drive the market growth over the forecast period.

Market Dynamics:

Global Alzheimer's drugs market growth is driven by rising geriatric population, increasing prevalence of Alzheimer's disease, introduction of novel disease modifying drugs, growing healthcare expenditure and rising awareness about the condition. However, high costs associated with drug R&D and failure of late stage clinical trials can hamper the market growth. Developing regions with large elderly populations an offer significant growth opportunities. Technological advancements in early diagnosis and advancements in understanding the disease pathology can also offer new opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global Alzheimer's drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Alzheimer's drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include AbbVie, Inc., Teva Pharmaceuticals Ltd., Eisai Co., Ltd., Janssen Pharmaceuticals, Inc. (Johnson & Johnson), Novartis AG, Zydus Lifesciences Ltd (CADILA), Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd, Aurobindo Pharma Ltd, Amneal Pharmaceuticals Inc., Macleods Pharmaceuticals Ltd., Viatris Inc., Lupin Ltd, Cipla Ltd., Torrent Pharmaceuticals Ltd., Unichem laboratories ltd, Lannett Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global Alzheimer's drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Alzheimer's drugs market

Detailed Segmentation-

• By Drug Class
  • Cholinesterase Inhibitors
  • Donepezil
  • Rivastigmine
  • Galantamine
  • NMDA Receptor Antagonist
  • Memantine
  • Combination Therapy
  • Donepezil and Memantine
  • Pipeline Drugs
  • Aducanumab
  • Lecanemab
  • Donanemab
• By Route of Administration
  • Oral
  • Parenteral
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie, Inc.
  • Teva Pharmaceuticals Ltd.
  • Eisai Co., Ltd.
  • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  • Novartis AG
  • Zydus Lifesciences Ltd (CADILA)
  • Sun Pharmaceutical Industries Ltd.
  • Reddy's Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Amneal Pharmaceuticals Inc.
  • Macleods Pharmaceuticals Ltd.
  • Viatris Inc.
  • Lupin Ltd
  • Cipla Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Unichem laboratories ltd
  • Lannett Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Alzheimer's Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Alzheimer's Drugs Market, By Drug Class, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cholinesterase Inhibitors
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Donepezil
• Rivastigmine
• Galantamine
• NMDA Receptor Antagonist
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Memantine
• Combination Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Donepezil and Memantine
• Pipeline Drugs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Aducanumab
• Lecanemab
• Donanemab

6. Global Alzheimer's Drugs Market, By Route of Administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Parenteral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Alzheimer's Drugs Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Alzheimer's Drugs Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • AbbVie, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceuticals Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eisai Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  • Novartis AG
  • Zydus Lifesciences Ltd (CADILA)
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd
  • Aurobindo Pharma Ltd
  • Amneal Pharmaceuticals Inc.
  • Macleods Pharmaceuticals Ltd.
  • Viatris Inc.
  • Lupin Ltd
  • Cipla Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Unichem laboratories ltd
  • Lannett Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact